CTLA4 and neoplasm: This subtype is associated with enhanced local anti-tumor immunity, where infiltrating CD8+ T cells show increased cytolytic activity, accompanied by increased expression of co-regulatory molecules (CTLA-4, PD-L1, PD-L2, and IDO-1).